Home › Funds › Royce & Associates › DFTX
Royce & Associates position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)208.55K sh
Reported value held$9.81M
Portfolio Weight0.08%
First reportedQ1 2026
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 234.05K | $4.42M | New |
| Q2 2026 | 208.55K | $9.81M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DFTX
- BlackRock Inc 11.23M sh · $528.39M · Q2 2026
- Capital World Investors 5.37M sh · $252.50M · Q2 2026
- Fidelity Management & Research (FMR) 4.75M sh · $223.58M · Q2 2026
- Geode Capital Management 3.64M sh · $171.48M · Q2 2026
- Wellington Management Group 2.95M sh · $138.76M · Q2 2026
- Citadel Advisors 2.26M sh · $106.36M · Q2 2026
- Goldman Sachs Group 1.80M sh · $84.71M · Q2 2026
- Marshall Wace 1.30M sh · $61.10M · Q2 2026
- Northern Trust Corp 1.17M sh · $55.00M · Q2 2026
- Charles Schwab Investment Management 1.08M sh · $50.97M · Q2 2026
- Two Sigma Investments 921.82K sh · $43.36M · Q2 2026
- Balyasny Asset Management 897.66K sh · $42.23M · Q2 2026